3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
2
Sponsor Class
OTHER
20
NIH
3
INDUSTRY
2
FED
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Barrett Esophagus
2
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
1019
Carboplatin
959
Paclitaxel
932
Gemcitabine
793
Cisplatin
748
Docetaxel
682
Bevacizumab
610
Pemetrexed
502
Nivolumab
486
Cyclophosphamide
466
Capecitabine
461
Fluorouracil
417
Dexamethasone
402
Rituximab
372
Oxaliplatin
347
Injections
342
atezolizumab
297
Trastuzumab
297
Leucovorin
286
Cetuximab
282
Irinotecan
266
130-nm albumin-bound paclitaxel
252
Prednisone
244
Doxorubicin
240
Ipilimumab
226
Lenalidomide
220
Fulvestrant
217
fludarabine
214
durvalumab
205
Erlotinib Hydrochloride
188
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Interventional
×
Endoscopy, Digestive System
×
Clear all
NCT04295811
2023-01-25
ESOGUARDBE2
PAVmed Inc.
Phase NA
Unknown
470 enrolled
NCT02864043
2020-03-04
DDP
NinePoint Medical
Phase NA
Unknown
150 enrolled